Equity Transactions (Details 3) - Warrant [Member] - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Number of shares, beginning | 193,203 | 77,703 | |
| Weighted average exercise price, beginning | $ 140.30 | $ 206.00 | |
| Weighted average remaining life (Years) | 4 years 1 month 6 days | 4 years | 4 years |
| Aggregate intrinsic value, outstanding at beginning | $ 18,318,954 | ||
| Number of shares, granted | 1,018,210 | 175,500 | |
| Weighted average exercise price, granted | $ 16.54 | $ 131.40 | |
| Weighted average remaining life (Years), granted | 4 years 9 months 18 days | 5 years | |
| Number of shares, exercised | (250,297) | (60,000) | |
| Weighted average exercise price, exercised | $ 15.31 | $ 100.00 | |
| Number of shares, expired | (1,018) | ||
| Weighted average exercise price, expired | $ 218.81 | ||
| Number of shares, ending | 960,098 | 193,203 | 77,703 |
| Weighted average exercise price, ending | $ 35.02 | $ 140.30 | $ 206.00 |
| Aggregate intrinsic value, outstanding at ending | $ 18,318,954 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|